Aim: This study aimed to compare the clinical efficacy of posterior lumbar interbody fusion (PLIF), percutaneous intralaminar screw pars stabilization (PS), and conservative treatment (CT) for symptomatic spondylolysis (SL).
Material and Method: A retrospective randomized study was conducted on 45 patients, with 15 in each group (PLIF, PS, and CT), who underwent bilateral L5 SL and were treated between 2017 and 2022. Surgical indications included low back pain lasting >6 months that was unresponsive to CT and without sciatica. The CT group comprised patients with similar pain profiles. Clinical outcomes were measured using the visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form 36 (SF-36) scores at 0, 1, 3, 6, and 12 months.
Results: The study included 65% female patients with a mean age of 52 (PLIF), 44 (PS), and 46 (CT) years. Both the PS and PLIF groups showed significant clinical improvement compared with the CT group (p<0.05). No intraoperative complications were observed. The mean hospital stay was shorter in the PS group (2.7±1.3 days) than in the PLIF group (5.4±1.8 days). The operation time was 40±15 minutes for PS and 168±41 minutes for PLIF, with blood loss of 50±15 cc for PS and 350±170 cc for PLIF.
Conclusion: PS and PLIF resulted in better clinical outcomes than CT for L5 spondylolysis. PS is a minimally invasive and safe option with less muscle and soft tissue disruption; however, the final follow-up scores did not differ significantly between the PS and PLIF groups.
Spondylolysis pars stabilization isthmic defect intralaminar screw conservative treatment
Ethical Approval: This study protocol was approved by the Kanuni Sultan Süleyman Training and Research Hospital Ethical Review Board (Subject No: KAEK/2022.02.38; approval date: 10/02/2022). All the procedures were performed in accordance with the principles of the Declaration of Helsinki.
-
-
| Birincil Dil | İngilizce |
|---|---|
| Konular | Beyin ve Sinir Cerrahisi (Nöroşirurji) |
| Bölüm | Özgün Makaleler |
| Yazarlar | |
| Yayımlanma Tarihi | 15 Ocak 2025 |
| Gönderilme Tarihi | 8 Ekim 2024 |
| Kabul Tarihi | 11 Kasım 2024 |
| Yayımlandığı Sayı | Yıl 2025 Cilt: 7 Sayı: 1 |
Chief Editors
Prof. Dr. Berkant Özpolat, MD
Department of Thoracic Surgery, Ufuk University, Dr. Rıdvan Ege Hospital, Ankara, Türkiye
Editors
Prof. Dr. Sercan Okutucu, MD
Department of Cardiology, Ankara Lokman Hekim University, Ankara, Türkiye
Assoc. Prof. Dr. Süleyman Cebeci, MD
Department of Ear, Nose and Throat Diseases, Gazi University Faculty of Medicine, Ankara, Türkiye
Field Editors
Assoc. Prof. Dr. Doğan Öztürk, MD
Department of General Surgery, Manisa Özel Sarıkız Hospital, Manisa, Türkiye
Assoc. Prof. Dr. Birsen Doğanay, MD
Department of Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye
Assoc. Prof. Dr. Sonay Aydın, MD
Department of Radiology, Erzincan Binali Yıldırım University Faculty of Medicine, Erzincan, Türkiye
Language Editors
PhD, Dr. Evin Mise
Department of Work Psychology, Ankara University, Ayaş Vocational School, Ankara, Türkiye
Dt. Çise Nazım
Department of Periodontology, Dr. Burhan Nalbantoğlu State Hospital, Lefkoşa, North Cyprus
Statistics Editor
Dr. Nurbanu Bursa, PhD
Department of Statistics, Hacettepe University, Faculty of Science, Ankara, Türkiye
Scientific Publication Coordinator
Kübra Toğlu
argistyayincilik@gmail.com
Franchise Owner
Argist Yayıncılık
argistyayincilik@gmail.com
Publisher: Argist Yayıncılık
E-mail: argistyayincilik@gmail.com
Phone: 0312 979 0235
GSM: 0533 320 3209
Address: Kızılırmak Mahallesi Dumlupınar Bulvarı No:3 C-1 160 Çankaya/Ankara, Türkiye
Web: www.argistyayin.com.tr